Skip to content
411 PRESS
WarningRecall #D-0295-2026Drug / Pharmaceutical

Zydus Pharmaceuticals (USA) Inc Recalls Icosapent Ethyl capsules

Zydus Pharmaceuticals (USA) Inc · Class II — Moderate Risk

Assorted pharmaceutical pills and tablets — representative photo for FDA drug recall
An assortment of pharmaceutical pills (representative file photo). Specific recalled product: see recall details below. Photo: Michael Nutt / Wikimedia Commons (CC BY-SA 2.0).

Product Description

Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07

Reason for Recall

Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules

FDA Classification

Class II — Moderate Risk

A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

Distribution

US Nationwide.

Remedy

Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.

Independent news on labor, safety, and accountability.